P3 Health Partners (PIII) Stock Statistics & Valuation Metrics

P3 Health Partners has a market cap or net worth of $78.25M. The enterprise value is $73.76M.

P3 Health Partners has 3,325,858 shares outstanding. The number of shares has decreased by -2.65% in one year.

P3 Health Partners’s return on equity (ROE) is 0.95 and return on invested capital (ROIC) is -172.80%.

The current PE Ratio of P3 Health Partners is ―. P3 Health Partners’s PEG ratio is 0.02.

In the last 12 months, P3 Health Partners had revenue of 1.46B and earned -147.95M in profits. Earnings per share was -45.26.

In the last 12 months, operating cash flow was -85.24M and capital expenditures 79.00K, giving a free cash flow of -85.16M billion.

P3 Health Partners pays an annual dividend of ―, resulting in a dividend yield of ―

P3 Health Partners upcoming earnings date is Aug 11, 2026, After Close (Confirmed).

P3 Health Partners as a current ratio of 0.24, with Debt / Equity ratio of -43.38%

In the past 12 months, P3 Health Partners has paid 2.02M in taxes.

P3 Health Partners EV to EBITDA ratio is -1.46, with an EV/FCF ratio of -2.98.

P3 Health Partners has $25.50M in cash and marketable securities with $62.27M in debt, giving a net cash position of -$36.77M billion.

Gross margin is 50.63%, with operating margin of -18.53%, and net profit margin of -10.14%.

The average price target for P3 Health Partners is $488.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy